Quinn, Tom M ;
Gaughan, Erin E ;
Bruce, Annya...
Quinn , T M , Gaughan , E E , Bruce , A , Antonelli , J , O'Connor , R , Li , F , McNamara , S , Koch , O , MacKintosh , C , Dockrell , D , Walsh , T , Blyth , K G , Church , C , Schwarze , J , Boz , C , Valanciute , A , Burgess , M , Emanuel , P , Mills , B , Rinaldi , G , Hardisty , G , Mills , R , Findlay , E G , Jabbal , S , Duncan , A , Plant , S , Marshall , A D L , Young , I , Russell , K , Scholefield , E , Nimmo , A F , Nazarov , I B , Churchill , G C , McCullagh , J S O , Ebrahimi , K H , Ferrett , C , Templeton , K , Rannard , S , Owen , A , Moore , A , Finlayson , K , Shankar-Hari , M , Norrie , J , Parker , R A , Akram , A R , Anthony , D C , Dear , J W , Hirani , N & Dhaliwal , K 2022 , ' Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis : Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics ' , EBioMedicine , vol. 76 , 103856 . https://doi.org/10.1016/j.ebiom.2022.103856.
,
2022
